Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

Université de Montréal

$17,500.00

Functional characterization of METTL7B, a biomarker in KMT2A-MLLT3 translocated acute myeloid leukemia

EF 2020-21

Résumé
METTL7B (a putative methyltransferase) has been found to be highly expressed in AML cells with the KMT2A-MLLT3 gene fusion (KM3 known hereafter) but not expressed in other blood cell types, and therefore represents a novel biomarker. The METTL7B protein remains uncharacterized and therefore it is unclear whether it has a functional role in the development of leukemia. Previous research in other cell types has suggested it may interact with mitochondria associated proteins or in pathways regulating cell proliferation. Our preliminary data suggest that METTL7B expression is essential for KM3-AML and that it may influence RNA processing. To further define its biological importance, we will: 1. Determine the intracellular localization METTL7B in HeLa cells (as a control), and then in KM3-AML cells by using an EGFP-tagged METTL7B and confocal fluorescence microscopy. 2. Identify METTL7B interacting proteins in HeLa cells (as a control), and then in KM3-AML cells by completing co-immunoprecipitation assays with EGFP-METT7B followed by LC-MS/MS analysis. 3. Perform modified RNA-seq studies to elucidate putative METTL7B methylation targets in leukemic cells. This will be followed by an analysis of the surrounding sequence of the methylation site to determine if METTL7B targets contain a specific recognition motif. Since METTL7B is a biomarker for KM3-AML, analysis of its targets and localization should identify the changes in cellular properties associated within the translocation. Therefore, from the results of the methods proposed, I should be able to determine the potential functions of METTL7B and its role in KM3-AML.
Programme
Master's Award: Canada Graduate Scholarships
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
449415
Name
Denford Sarah
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Functional characterization of METTL7B, a biomarker in KMT2A-MLLT3 translocated acute myeloid leukemia
Programtype2
Studentship Programs
Orgnameinp2
Université de Montréal
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Acute Myeloid Leukemia; Biomarker; Function; Localization; Methyltransferase
Abstract
METTL7B (a putative methyltransferase) has been found to be highly expressed in AML cells with the KMT2A-MLLT3 gene fusion (KM3 known hereafter) but not expressed in other blood cell types, and therefore represents a novel biomarker. The METTL7B protein remains uncharacterized and therefore it is unclear whether it has a functional role in the development of leukemia. Previous research in other cell types has suggested it may interact with mitochondria associated proteins or in pathways regulating cell proliferation. Our preliminary data suggest that METTL7B expression is essential for KM3-AML and that it may influence RNA processing. To further define its biological importance, we will: 1. Determine the intracellular localization METTL7B in HeLa cells (as a control), and then in KM3-AML cells by using an EGFP-tagged METTL7B and confocal fluorescence microscopy. 2. Identify METTL7B interacting proteins in HeLa cells (as a control), and then in KM3-AML cells by completing co-immunoprecipitation assays with EGFP-METT7B followed by LC-MS/MS analysis. 3. Perform modified RNA-seq studies to elucidate putative METTL7B methylation targets in leukemic cells. This will be followed by an analysis of the surrounding sequence of the methylation site to determine if METTL7B targets contain a specific recognition motif. Since METTL7B is a biomarker for KM3-AML, analysis of its targets and localization should identify the changes in cellular properties associated within the translocation. Therefore, from the results of the methods proposed, I should be able to determine the potential functions of METTL7B and its role in KM3-AML.
Competitiondate
202012
Approvedterm2
1 yr 0 mth
Pinamesdelim
Denford, Sarah
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~